DeepMed Research

Aspartic acid

Generic Name: Aspartic acid

Brand Names: Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinisol 15, Olimel, Periolimel, Plenamine, Premasol, Primene, Prosol, Trophamine 10 %

Drug Type: Small Molecule

Chemical Formula: C_₄H_₇NO_₄

CAS Number: 56-84-8

Unique Ingredient Identifier: 30KYC7MIAI

Background: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.

Indication: There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

Associated Therapies: Amino acid supplementation

Clinical Trials

Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers

Phase 1

Completed

Conditions: Heart Failure

Interventions: Drug: Treatment A
Drug: Treatment F
Drug: Treatment B
Drug: Treatment C
Drug: Treatment G
Drug: Treatment D
Drug: Treatment H
Drug: Treatment E

First Posted Date: 2021-03-15

Last Posted Date: 2021-09-09

Lead Sponsor: AstraZeneca

Target Recruit Count: 20

Registration Number: NCT04798222

Locations: 🇩🇪
Research Site, Berlin, Germany

Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia

Phase 3

Conditions: Covid-19

Interventions: Drug: Placebo
Drug: Ivermectin
Drug: ASP

First Posted Date: 2021-01-11

Last Posted Date: 2021-06-04

Lead Sponsor: London School of Hygiene and Tropical Medicine

Target Recruit Count: 1200

Registration Number: NCT04703608

Locations: 🇬🇲
Mrcg@Lshtm, Fajara, Gambia

The Benefits of Vitamin D 5000 IU as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient

Phase 2

Conditions: Painful Diabetic Neuropathy

Interventions: Drug: Standard therapy
Drug: Vitamin D 5,000IU Oral Tablet

First Posted Date: 2020-12-30

Last Posted Date: 2020-12-30

Lead Sponsor: Duta Wacana Christian University

Target Recruit Count: 60

Registration Number: NCT04689958

Locations: 🇮🇩
Bethesda Hospital Yogyakarta, Yogyakarta, Special Region Of Yogyakarta, Indonesia

Effect of Vitamin d Deficiency in Chronic Rhinosinusitis With Nasal Polyposis

Phase 1

Conditions: Vitamin D Deficiency, Nasal Polyposis

Interventions: Drug: usual therapy for nasal polyposis
Drug: vitamin D supplementation

First Posted Date: 2020-08-27

Last Posted Date: 2020-08-31

Lead Sponsor: Ain Shams University

Target Recruit Count: 50

Registration Number: NCT04529668

Locations: 🇪🇬
Ain shams Univesrity, Cairo, Egypt

P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release

Phase 2

Completed

Conditions: Pharmacokinetics

Interventions: Drug: Treatment A
Drug: Treatment B
Drug: Treament C
Drug: Treatment D
Biological: Pharmacocinetik
Genetic: Genetic

First Posted Date: 2020-07-28

Last Posted Date: 2024-12-11

Lead Sponsor: Rennes University Hospital

Target Recruit Count: 27

Registration Number: NCT04489134

Locations: 🇫🇷
CHU de Rennes, Rennes, France

A Study to Evaluate Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 in Healthy Male Subjects

Phase 1

Conditions: Healthy

Interventions: Drug: IN-C005 dose E
Drug: IN-C005 dose B
Drug: IN-C005 dose D
Drug: IN-C005 dose A
Drug: IN-C005 dose C
Drug: IN-C005 dose F

First Posted Date: 2020-07-24

Last Posted Date: 2020-11-09

Lead Sponsor: HK inno.N Corporation

Target Recruit Count: 42

Registration Number: NCT04485884

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Short Term, High Dose Vitamin D Supplementation for COVID-19

Not Applicable

Completed

Conditions: COVID

Interventions: Drug: Vit D

First Posted Date: 2020-07-07

Last Posted Date: 2021-11-02

Lead Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh

Target Recruit Count: 40

Registration Number: NCT04459247

Locations: 🇮🇳
Deptt of Endocrinology, Chandigarh, India

A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts

Not Applicable

Completed

Conditions: Verruca Viral

Interventions: Drug: Vit D
Drug: Measles-Mumps-Rubella Vaccine

First Posted Date: 2020-06-11

Last Posted Date: 2021-04-09

Lead Sponsor: B.P. Koirala Institute of Health Sciences

Target Recruit Count: 66

Registration Number: NCT04428359

Locations: 🇳🇵
BP Koirala Institute of Health Sciences, Dharān Bāzār, One, Nepal

Exploring the Effects of Vitamin D Supplementation on the Chronic Course of Patients With Crohn's Disease With Vitamin D Deficiency

Early Phase 1

Conditions: Vitamin D Deficiency
Crohn's Disease
Vitamin D Supplement

Interventions: Drug: Vitamin D drops

First Posted Date: 2020-03-16

Last Posted Date: 2020-10-14

Lead Sponsor: Second Affiliated Hospital of Wenzhou Medical University

Target Recruit Count: 60

Registration Number: NCT04308850

Locations: 🇨🇳
SAHWenzhouMU, Wenzhou, Zhejiang, China

Observation of the Effect of Vitamin D Supplementation on Chronic Course of Patients With Ulcerative Colitis Based on Vitamin D Receptor Fok I Gene Polymorphism

Early Phase 1

Conditions: Ulcerative Colitis
Vitamin D Deficiency
Vitamin D Supplement

Interventions: Drug: Vitamin D drops

First Posted Date: 2020-03-16

Last Posted Date: 2020-03-16

Lead Sponsor: Second Affiliated Hospital of Wenzhou Medical University

Target Recruit Count: 100

Registration Number: NCT04309058

Locations: 🇨🇳
SAHWenzhouMU, Wenzhou, Zhejiang, China

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy